Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
Divisions of Infectious Disease,
Received 22 August 1997/Returned for modification 5 December
1997/Accepted 15 March 1997
New antibiotic regimens are needed for the treatment of
multidrug-resistant tuberculosis. Mycobacterium
tuberculosis has a thick peptidoglycan layer, and the
penicillin-binding proteins involved in its biosynthesis are inhibited
by clinically relevant concentrations of
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Recombinant Expression and Characterization of the
Major
-Lactamase of Mycobacterium tuberculosis
-lactam antibiotics.
-Lactamase production appears to be the major mechanism by which
M. tuberculosis expresses
-lactam resistance.
-Lactamases from the broth supernatant of 3- to 4-week-old cultures
of M. tuberculosis H37Ra were partially purified by
sequential gel filtration chromatography and chromatofocusing. Three
peaks of
-lactamase activity with pI values of 5.1, 4.9, and 4.5, respectively, and which accounted for 10, 78, and 12% of the total
postchromatofocusing
-lactamase activity, respectively, were
identified. The
-lactamases with pI values of 5.1 and 4.9 were
kinetically indistinguishable and exhibited predominant penicillinase activity. In contrast, the
-lactamase with a pI value of 4.5 showed
relatively greater cephalosporinase activity. An open reading frame in
cosmid Y49 of the DNA library of M. tuberculosis H37Rv with homology to known class A
-lactamases was amplified from chromosomal DNA of M. tuberculosis H37Ra by PCR and
was overexpressed in Escherichia coli. The recombinant
enzyme was kinetically similar to the pI 5.1 and 4.9 enzymes purified
directly from M. tuberculosis. It exhibited
predominant penicillinase activity and was especially active against
azlocillin. It was inhibited by clavulanic acid and
m-aminophenylboronic acid but not by EDTA. We conclude that the major
-lactamase of M. tuberculosis is a class
A
-lactamase with predominant penicillinase activity. A second,
minor
-lactamase with relatively greater cephalosporinase activity
is also present.
*
Corresponding author. A-3310 MCN, Vanderbilt
University, 1161 21st Ave. South, Nashville, TN 37212-2605. Phone:
(615) 327-4751, ext. 5486. Fax: (615) 343-6160. E-mail:
doug.kernodle{at}vanderbilt.edu.
Antimicrobial Agents and Chemotherapy, June 1998, p. 1375-1381, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»